Is Agen a good value stock to buy now?
AGEN has a Quality Grade of C, ranking ahead of 55.26% of graded US stocks. AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks. COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN.
How do I buy shares of Agen?
Shares of AGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How does Agen's asset turnover rank among pharmaceutical products stocks?
AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks. COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN. The table below shows AGEN's key quality metrics over time.
What is the price targets for Agenus Inc (AGN) stock?
The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $11.50, Agenus has a forecasted upside of 221.2% from its current price of $3.58.
See more
Is AGEN stock worth buying?
Agenus Inc (NASDAQ:AGEN) The 2 analysts offering 12-month price forecasts for Agenus Inc have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +417.24% increase from the last price of 1.45.
Why is AGEN stock going up?
A strong agreement among sell-side analysts covering AGEN in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 1.2% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
What is AGEN Robinhood?
It's a clean, easy-to-use interface. You can even get a free stock for signing up. I received a free share of a company called Agenus, trading under the symbol of AGEN for $3.28, a company described in my Robinhood portfolio as a “clinical-stage immuno-oncology company.”
Why did AGEN drop today?
Shares of Agenus (NASDAQ: AGEN) dropped more than 32% this morning after the company gave investors bad news regarding its experimental cancer immunotherapy balstilimab. The company has withdrawn the Biologics License Application (BLA) that the Food and Drug Administration (FDA) began reviewing earlier this year.
What does agenus company do?
Agenus is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
Will agenus go back up?
The Wall Street analyst predicted that AGENUS's share price could reach $14.00 by Mar 2, 2023. The average AGENUS stock price prediction forecasts a potential upside of 775% from the current AGEN share price of $1.60.
What went wrong with Robinhood?
The trading platform, which just reported billions in losses for 2021, is still contending with lawsuits, trading restrictions and regulatory scrutiny. As a subscriber, you have 10 gift articles to give each month.
Is Robinhood safe?
YES–Robinhood is absolutely safe. Your funds on Robinhood are protected up to $500,000 for securities and $250,000 for cash claims because they are a member of the SIPC. Furthermore, Robinhood is a securities brokerage and as such, securities brokerages are regulated by the Securities and Exchange Commission (SEC).
How is Robinhood unethical?
Robinhood claims it is 'free' however, it makes money by payment for order flow. This means they send orders to be executed by trading firms in return for cash payments. These activities are not typical for broker-dealers and raise 'red flags' about the integrity of the business model.
When did agenus go public?
The company has pioneered immunotherapies, including heat shock protein-based cancer vaccines, a program that has developed into its Prophage Series of personalized anti-cancer vaccines. Antigenics became a public company in February 2000 on the NASDAQ exchange with the ticker symbol AGEN.
Should I buy or sell Agenus stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agenus in the last twelve months. There are currently 2...
What is Agenus' stock price forecast for 2022?
2 equities research analysts have issued 12 month price objectives for Agenus' stock. Their forecasts range from $8.00 to $14.00. On average, they...
How has Agenus' stock price performed in 2022?
Agenus' stock was trading at $3.22 at the start of the year. Since then, AGEN stock has decreased by 54.7% and is now trading at $1.46. View the b...
When is Agenus' next earnings date?
Agenus is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for Agenus .
How were Agenus' earnings last quarter?
Agenus Inc. (NASDAQ:AGEN) released its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported ($0.19) EPS for the quarte...
Who are Agenus' key executives?
Agenus' management team includes the following people: Dr. Garo H. Armen Ph.D. , Founder, Exec. Chairman & CEO (Age 69, Pay $1.07M) Ms. Christin...
What is Garo H. Armen's approval rating as Agenus' CEO?
2 employees have rated Agenus CEO Garo H. Armen on Glassdoor.com . Garo H. Armen has an approval rating of 56% among Agenus' employees. This puts...
Who are some of Agenus' key competitors?
Some companies that are related to Agenus include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceuti...
What other stocks do shareholders of Agenus own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Agenus investors own include (ROSG) (ROSG) , Exelixis (EX...
Is Agenus stock a Buy, Sell or Hold?
Agenus stock has received a consensus rating of buy. The average rating score is and is based on 2 buy ratings, 0 hold ratings, and 0 sell ratings.
What was the 52-week low for Agenus stock?
The low in the last 52 weeks of Agenus stock was 1.40. According to the current price, Agenus is 104.29% away from the 52-week low.
What was the 52-week high for Agenus stock?
The high in the last 52 weeks of Agenus stock was 6.79. According to the current price, Agenus is 21.52% away from the 52-week high.
What are analysts forecasts for Agenus stock?
The 2 analysts offering price forecasts for Agenus have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 12.00. The me...
How much is Agenus stock worth in 2021?
Is Agenus a sell or buy signal?
The Agenus Inc. stock price gained 1.62% on the last trading day (Friday, 9th Jul 2021), rising from $5.55 to $5.64. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 2.91% from a day low at $5.49 to a day high of $5.65. The price has risen in 7 of the last 10 days and is up by 3.49% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 2 million shares were bought and sold for approximately $13.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Where is Agenus located?
The Agenus Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance ...
When is Agenus meeting 2021?
Agenus Inc. engages in discovering and developing innovative treatments for patients with cancer and other diseases. The company was founded in 1994 and is based in Lexington, Massachusetts.
What is Agenus Inc?
LEXINGTON, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that its annual meeting will begin at 5:00 p.m. ET on June 15, 2021 and will be conducted in a virtual format only. Registration for attendees will start at 4:45 p.m. ET. To participate in the Annual Shareholders Meeting, sha
What is an X industry?
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
What is a strong weekly advance?
The X Industry (aka Expanded Industry) is a subset of the M (Medium Sized) Industry, which is a subset of the larger Sector category, which is used to classify all of the stocks in the Zacks Universe. The Zacks database contains over 10,000 stocks.
